Metabolite profiling of plasma and urine from rats with TNBS‐induced acute colitis using UPLC‐ESI‐QTOF‐MS‐based metabonomics – a pilot study
Open Access
- 21 April 2012
- journal article
- Published by Wiley in The FEBS Journal
- Vol. 279 (13) , 2322-2338
Abstract
The incidence of inflammatory bowel disease, a relapsing intestinal condition whose precise etiology is still unclear, has continually increased over recent years. Metabolic profiling is an effective method with high sample throughput that can detect and identify potential biomarkers, and thus may be useful in investigating the pathogenesis of inflammatory bowel disease. In this study, using a metabonomics approach, a pilot study based on ultra‐performance liquid chromatography coupled with electrospray ionization quadrupole time‐of‐flight mass spectrometry (UPLC‐ESI‐QTOF‐MS) was performed to characterize the metabolic profile of plasma and urine samples of rats with experimental colitis induced by 2,4,6‐trinitrobenzene sulfonic acid. Acquired metabolic profile data were processed by multivariate data analysis for differentiation and screening of potential biomarkers. Five metabolites were identified in urine: two tryptophan metabolites [4‐(2‐aminophenyl)‐2,4‐dioxobutanoic acid and 4,6‐cihydroxyquinoline], two gut microbial metabolites (phenyl‐acetylglycine and p‐cresol glucuronide), and the bile acid 12α‐hydroxy‐3‐oxocholadienic acid. Seven metabolites were identified in plasma: three members of the bile acid/alcohol group (cholic acid, 12α‐hydroxy‐3‐oxocholadienic acid and cholestane‐3,7,12,24,25‐pentol) and four lysophosphatidylcholines [LysoPC(20:4), LysoPC(16:0), LysoPC(18:1) and LysoPC(18:0)]. These metabolites are associated with damage of the intestinal barrier function, microbiota homeostasis, immune modulation and the inflammatory response, and play important roles in the pathogenesis of inflammatory bowel disease. Our results positively support application of the metabonomic approach in study of the pathophysiological mechanism of inflammatory bowel disease.Keywords
This publication has 46 references indexed in Scilit:
- Defective Leukocyte GM-CSF Receptor (CD116) Expression and Function in Inflammatory Bowel DiseaseGastroenterology, 2011
- Intestinal microbiota in inflammatory bowel disease: Friend of foe?World Journal of Gastroenterology, 2011
- Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitisInflammatory Bowel Diseases, 2011
- Bile Acids Induce Inflammatory Genes in HepatocytesThe American Journal of Pathology, 2011
- Animal models of IBD: linkage to human diseaseCurrent Opinion in Pharmacology, 2010
- Gut hormones: emerging role in immune activation and inflammationClinical and Experimental Immunology, 2010
- Inflammation in the Intestinal Tract: Pathogenesis and TreatmentDigestive Diseases, 2009
- Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysisBMC Genomics, 2008
- Metabolomics Reveals that Hepatic Stearoyl-CoA Desaturase 1 Downregulation Exacerbates Inflammation and Acute ColitisCell Metabolism, 2008